| 1 | Abatacept Placebo | 1件:  Abatacept Abatacept | 1件:  D03203 
                
                    D03203
                
             | 2件:  CD80 CD80, CD86 💬 | 12件:  Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 2件:  46 46, 53 | 
| 2 | Biological: Benralizumab, Biological: Placebo to Mepolizumab | 2件:  Benralizumab Benralizumab, Mepolizumab | 2件:  D04923 
                
                    D04923
                
            , 
                
                    D09874
                
             | 2件:  IL5 IL5, IL5RA 💬 | 13件:  Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件:  44 44 | 
| 3 | Biological: Mepolizumab, Biological: Placebo to Benralizumab | 2件:  Benralizumab Benralizumab, Mepolizumab | 2件:  D04923 
                
                    D04923
                
            , 
                
                    D09874
                
             | 2件:  IL5 IL5, IL5RA 💬 | 13件:  Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件:  44 44 | 
| 4 | Crema placebo (excipiente) | - | - | - | - | 1件:  157 157 | 
| 5 | HP-3000 placebo | - | - | - | - | 1件:  6 6 | 
| 6 | Methotrexate Placebo | 1件:  Methotrexate Methotrexate | 2件:  D00142 
                
                    D00142
                
            , 
                
                    D02115
                
             | 2件:  DHFR DHFR, DHFR2 💬 | 5件:  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件:  46 46 | 
| 7 | NS-304 Placebo | - | - | - | - | 2件:  70 70, 88 | 
| 8 | Placebo | - | - | - | - | 27件:  3 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 | 
| 9 | Placebo (physiological saline) | - | - | - | - | 2件:  43 43, 45 | 
| 10 | Placebo IV | - | - | - | - | 1件:  50 50 | 
| 11 | Placebo SC | - | - | - | - | 1件:  50 50 | 
| 12 | Ropinirole hydrochloride extended-release tablet placebo | 1件:  Ropinirole Ropinirole | 2件:  D00784 
                
                    D00784
                
            , 
                
                    D08489
                
             | 3件:  DRD2 DRD2, DRD3, DRD4 💬 | 8件:  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件:  6 6 | 
| 13 | Vedolizumab Intravenous (IV), Vedolizumab Subcutaneous (SC), Placebo IV | 1件:  Vedolizumab Vedolizumab | 1件:  D08083 
                
                    D08083
                
             | 2件:  ITGA4 ITGA4, ITGB7 💬 | 15件:  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件:  97 97 | 
| 14 | Vedolizumab IV, Placebo IV, Placebo SC | 1件:  Vedolizumab Vedolizumab | 1件:  D08083 
                
                    D08083
                
             | 2件:  ITGA4 ITGA4, ITGB7 💬 | 15件:  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件:  97 97 | 
| 15 | Vedolizumab IV, Placebo SC | 1件:  Vedolizumab Vedolizumab | 1件:  D08083 
                
                    D08083
                
             | 2件:  ITGA4 ITGA4, ITGB7 💬 | 15件:  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件:  97 97 |